Chemists Honored for Natural Products and RNA Innovations That Changed Science (The Wertheim UF Scripps Institute)

Two UF researchers have been honored for groundbreaking work in natural products and RNA science, advancing discoveries that continue to influence drug development and biomedical innovation.
Universities, NASA and Space Companies Meet To Discuss the Future of Florida’s Space Ecosystem (UF News)

UF researchers joined partners at Kennedy Space Center to launch the next phase of the Florida Space Research Consortium, advancing collaboration in space research, innovation and workforce development.
How Space-Based Sensors Can Detect Nuclear Activity (UF News)

University of Florida researchers are developing advanced space-based technologies to improve the reliability and accuracy of detecting nuclear activity.
Candidate Breast Cancer Drug Overloads Tumors With “Surge” of Toxic Lipids (UF News)

A new drug targeting triple-negative breast cancer boosts ceramide production to stress and kill cancer cells, showing low toxicity in early studies but requiring further research before human trials.
Music-Based Rhythm Improves Gait in Parkinson’s Patients (UF Health)

A UF research team found that walking to music improves gait in both Parkinson’s patients and healthy older adults more effectively than a metronome or no auditory cue.
UF’s HiPerGator Drives FNN’s AI Wildfire Detection in Verizon Prize Recognition (HPC Wire)

UF Innovate | Accelerate resident client FNN won Verizon’s Disaster Resilience Prize for using AI to enhance disaster response and grid resilience.
Tech Tuesday: University of Florida Lab Uses Virtual Humans To Make Healthcare More Accessible (WCJB TV20)

In this week’s Tech Tuesday, our partners at UF Innovate spotlights University of Florida research using virtual humans to improve healthcare access.
Mars Rover Detects Never-Before-Seen Organic Compounds in New Experiment (UF News)

A University of Florida–led study using NASA’s Curiosity rover found organic molecules on Mars that could indicate ancient life, though confirming their origin will require returning samples to Earth.
Atsena Therapeutics Receives Data Monitoring Committee Recommendation To Proceed With Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients With X-Linked Retinoschisis (Globe Newswire)

UF startup Atsena Therapeutics has been cleared to advance to the pivotal phase of its LIGHTHOUSE trial for a gene therapy targeting X-linked retinoschisis, with patient screening set to begin this month.
New UF/IFAS Office Aims To Create More Businesses, Commercial Products From Agricultural Research (UF News)

UF/IFAS launches the Office of Strategic Partnerships & Innovation to accelerate public-private partnerships, faculty entrepreneurship and commercialization of agricultural research.